NIH #2UG1CA233290-07
Network Lead Academic Participating Site: Memorial Sloan Kettering Cancer Center
- Amount
- $1.1M
- Period
- 2019-03-30 → 2032-02-29
- PIs
- 5
- Est. capacity / PI
- ~1 students
Awarded at SLOAN-KETTERING INST CAN RESEARCH
Ovarian cancer diagnosis and treatment · Reproductive Medicine
16 total · 1 active
NIH #2UG1CA233290-07
Awarded at SLOAN-KETTERING INST CAN RESEARCH
NIH #3UG1CA233290-06S1
Awarded at SLOAN-KETTERING INST CAN RESEARCH
NIH #5UG1CA233290-06
Awarded at SLOAN-KETTERING INST CAN RESEARCH
Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.
Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.
2026-06-15
2026-06-15
2026-06-15
2026-06-15
2026-06-15
International Journal of Gynecological Cancer · 2026-04-25
Efficacy and safety of fam-trastuzumab deruxtecan in recurrent HER2-positive endometrial cancer
Gynecologic Oncology · 2026-04-23
Gynecologic Oncology · 2026-04-23 · 2 citations
Gynecologic Oncology · 2026-04-23
Mutational landscape of endometrial carcinomas and their patient-derived xenografts
Gynecologic Oncology · 2026-04-23
Gynecologic Oncology · 2026-04-23
Gynecologic Oncology · 2026-04-23
Gynecologic Oncology · 2026-04-23 · 1 citations
Gynecologic Oncology · 2026-04-23
Gynecologic Oncology · 2026-04-23
Gynecologic Oncology · 2026-04-23
Gynecologic Oncology · 2026-04-23 · 1 citations
Molecular sub group and post immunotherapy analysis: Results from NRG GY012
Gynecologic Oncology · 2026-04-23
Gynecologic Oncology · 2026-04-23
Gynecologic Oncology · 2026-04-23